Tokyo: A Japanese employee of Astellas Pharma, sentenced to three years and six months ​in prison for espionage in China is ‌set to be released in mid-December and returned to Japan, Japanese media reported late on Saturday.

Kyodo news agency and ​Yomiuri newspaper among others reported the news, citing ​sources.

The man was detained in March 2023 on ⁠suspicion of spying. He was indicted in August ​2024 and sentenced in July 2025.

The ruling was "extremely ​regrettable", Japan's deputy chief cabinet secretary said after the sentencing, without identifying the individual or affiliation.

Astellas Pharma, Japan's foreign ministry and ​the Chinese embassy in Tokyo did not respond ​to telephone calls from Reuters seeking comment. China's foreign ministry ‌did ⁠not respond to a request for comment.

The case has been an irritant in Japan-China relations.

Ties between the two have deteriorated since Japanese Prime Minister Sanae Takaichi ​last year said ​a hypothetical ⁠Chinese attack on democratically governed Taiwan could trigger a military response from nearby ​Japan.

China subsequently urged its citizens not ​to travel ⁠to Japan, saying their safety was at risk. It also throttled exports to Japan of rare earths, minerals ⁠vital ​to the manufacture of products as ​varied as cars and weapons.

Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .